MiR-142-5p act as an oncogenic microRNA in colorectal cancer: Clinicopathological and functional insights.

导出原文传递

翻译打印收藏纠错

第一作者： Farhadul,Islam

第一单位： Cancer Molecular Pathology, School of Medicine and Griffith Health Institute, Griffith University, Gold Coast, Queensland, 4222, Australia; Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.

作者： Farhadul,Islam ^[1] ; Vinod,Gopalan ^[2] ; Jelena,Vider ^[3] ; Cu-Tai,Lu ^[4] ; Alfred K-Y,Lam ^[5]

作者单位： Cancer Molecular Pathology, School of Medicine and Griffith Health Institute, Griffith University, Gold Coast, Queensland, 4222, Australia; Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh. ^[1] Cancer Molecular Pathology, School of Medicine and Griffith Health Institute, Griffith University, Gold Coast, Queensland, 4222, Australia; School of Medical Science and Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia. ^[2] School of Medical Science and Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia. ^[3] Department of Surgery, Gold Coast University Hospital, Gold Coast, Queensland, Australia. ^[4] Cancer Molecular Pathology, School of Medicine and Griffith Health Institute, Griffith University, Gold Coast, Queensland, 4222, Australia. Electronic address: a.lam@griffith.edu.au. ^[5]

关键词 Colorectal cancer KLF6 Onco-miRNA Targeted therapy miR-142-5p